Pharmaceutical Deals That Gp Bullhound Has Been Involved In
GP Bullhound has invested in several companies including Monocl and Splunk. They have also been involved in humanitarian aid efforts in Ukraine and have expanded their business by opening new offices. They specialize in advising on mergers, acquisitions, and private placements for a variety of clients. In 2019, they invested in Glovo, a multi-category delivery company, and were ranked as top financial advisors in North America for private equity deals.
It seems that, based on the available information, GP Bullhound has primarily been involved in investments and advisory services for technology companies rather than pharmaceutical deals specifically. Their focus has been on mergers, acquisitions, and private placements for a variety of clients, particularly in the technology and innovation sector. While they have not been directly involved in pharmaceutical deals based on the available information, their expertise in financial advisory services positions them as key players in facilitating deals and investments across various industries.
Sources
Related Questions
Work fast from anywhere
Stay up to date and move work forward with BrutusAI on macOS/iOS/web & android. Download the app today.